Buprenorphine Products for the Treatment of Pain: Relative Risk of Abuse and Related Clinical Outcomes Compared to Full μ-Opioid Agonist Medications.
Saved in:
| Title: | Buprenorphine Products for the Treatment of Pain: Relative Risk of Abuse and Related Clinical Outcomes Compared to Full μ-Opioid Agonist Medications. |
|---|---|
| Authors: | Green JL; Inflexxion Division, Uprise Health, 2 Park Plaza, Suite 1200, Irvine, CA, 92614, USA. jgreen@inflexxion.com., Dailey-Govoni T; Inflexxion Division, Uprise Health, 2 Park Plaza, Suite 1200, Irvine, CA, 92614, USA., Vosburg SK; Inflexxion Division, Uprise Health, 2 Park Plaza, Suite 1200, Irvine, CA, 92614, USA. |
| Source: | Pain and therapy [Pain Ther] 2026 Jun; Vol. 15 (3), pp. 751-763. Date of Electronic Publication: 2026 Apr 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Adis Country of Publication: New Zealand NLM ID: 101634491 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8237 (Print) NLM ISO Abbreviation: Pain Ther Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2193-8237 |
|---|---|
| DOI: | 10.1007/s40122-026-00835-w |
